New Tool For Prostate Cancer Diagnosis

New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology1 support the use of PROGENSA PCA3 as a tool for diagnosing prostate cancer. The study confirms that PROGENSA PCA3, the world’s first gene-based urine test to help detect prostate cancer, can provide clinicians with valuable information that helps guide diagnosis. As awareness and clinical support for PROGENSA PCA3 grows, a unique new resource regarding prostate cancer has been launched.

More: continued here

Filed under: Prostate on April 2nd, 2008